- Home
- / Eurobio Scientific
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Eurobio Scientific financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€25.8
2024-10-29
Market Capitalization
€259.2 M
2024-10-29
Revenue
€154.2 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 50.4M | 58.9M | 188.5M | 183.7M | 152.2M | 129.7M | 154.2M |
| Cost of goods sold | 30.6M | 37.9M | 76.2M | 79.4M | 77.9M | 63.5M | 77.2M |
| Gross profit | 20.5M | 21.6M | 113.0M | 105.9M | 75.0M | 67.1M | 77.8M |
| Gross profit margin, % | 40.6% | 36.6% | 59.9% | 57.7% | 49.3% | 51.8% | 50.4% |
| Operating expense total | 15.4M | 14.6M | 24.7M | 27.9M | 34.5M | 43.8M | 50.4M |
| Depreciation and amortization | 3.4M | 3.5M | 7.0M | 7.9M | 9.6M | 13.1M | 14.1M |
| EBITDA | 5.0M | 6.9M | 88.2M | 78.0M | 40.5M | 23.3M | 27.4M |
| EBITDA margin, % | 10.0% | 11.8% | 46.8% | 42.5% | 26.6% | 18.0% | 17.8% |
| EBIT | 1.2M | 2.9M | 81.2M | 71.2M | 30.2M | 8.7M | 12.0M |
| EBIT margin, % | 2.4% | 5.0% | 43.1% | 38.8% | 19.8% | 6.7% | 7.8% |
| Interest income | 18.0K | 43.0K | 1.1M | 1.5M | |||
| Interest expense | 1.1M | 748.0K | 619.0K | 455.0K | 1.3M | 4.4M | 8.3M |
| Pre tax profit | (32.0K) | 3.0M | 80.9M | 71.3M | 29.7M | 7.0M | 6.3M |
| Income tax expense | (52.0K) | (3.0M) | 7.4M | 10.8M | 4.7M | 2.1M | 2.3M |
| Net Income | 20.0K | 6.0M | 73.5M | 60.5M | 24.9M | 4.8M | 4.0M |